News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Deals
Daiichi Sankyo, Inc. in Buyout Talks With 3 Mid-sized Companies
February 7, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Daiichi Sankyo, which in 2008 acquired Ranbaxy, is in takeover talks with at least three mid-sized Indian pharmaceutical companies, The Economic Times today reported, citing unnamed sources.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Asia
Daiichi Sankyo
MORE ON THIS TOPIC
IPO
TRexBio, Retension raise $161.7M in IPOs; City, Iambic set proposed offering terms
October 9, 2026
·
3 min read
·
Gabrielle Masson
Deals
Viatris inks $1.65B Pacira buyout to build non-opioid pain therapy business
October 9, 2026
·
2 min read
·
Nick Paul Taylor
Manufacturing
Merck barred from making subcutaneous Keytruda in 8 European countries
October 8, 2026
·
2 min read
·
Nick Paul Taylor
Business
Genmab and AbbVie’s Epkinly win, a rush of deals, Sarepta’s turnaround hopes, more
October 7, 2026
·
2 min read
·
Jef Akst